Physiol Rev Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Rev. 86: 709-746, 2006; doi:10.1152/physrev.00016.2005
0031-9333/06 $18.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mullins, L. J.
Right arrow Articles by Mullins, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mullins, L. J.
Right arrow Articles by Mullins, J. J.

Hypertension, Kidney, and Transgenics: A Fresh Perspective

Linda J. Mullins, Matthew A. Bailey and John J. Mullins

Molecular Physiology Laboratory, Centre for Cardiovascular Science, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom

In this review, we outline the application and contribution of transgenic technology to establishing the genetic basis of blood pressure regulation and its dysfunction. Apart from a small number of examples where high blood pressure is the result of single gene mutation, essential hypertension is the sum of interactions between multiple environmental and genetic factors. Candidate genes can be identified by a variety of means including linkage analysis, quantitative trait locus analysis, association studies, and genome-wide scans. To test the validity of candidate genes, it is valuable to model hypertension in laboratory animals. Animal models generated through selective breeding strategies are often complex, and the underlying mechanism of hypertension is not clear. A complementary strategy has been the use of transgenic technology. Here one gene can be selectively, tissue specifically, or developmentally overexpressed, knocked down, or knocked out. Although resulting phenotypes may still be complicated, the underlying genetic perturbation is a starting point for identifying interactions that lead to hypertension. We recognize that the development and maintenance of hypertension may involve many systems including the vascular, cardiac, and central nervous systems. However, given the central role of the kidney in normal and abnormal blood pressure regulation, we intend to limit our review to models with a broadly renal perspective.





This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
Y. Zhou, J. Jiang, Y. Cui, and Q. Wu
Corin, atrial natriuretic peptide and hypertension
Nephrol. Dial. Transplant., April 1, 2009; 24(4): 1071 - 1073.
[Full Text] [PDF]


Home page
Exp PhysiolHome page
J.-P. Montani and B. N. Van Vliet
Understanding the contribution of Guyton's large circulatory model to long-term control of arterial pressure
Exp Physiol, April 1, 2009; 94(4): 382 - 388.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. H. Clarke, P. C. Emson, and R. F. Irvine
Localization of phosphatidylinositol phosphate kinase II{gamma} in kidney to a membrane trafficking compartment within specialized cells of the nephron
Am J Physiol Renal Physiol, November 1, 2008; 295(5): F1422 - F1430.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. A. Bailey, J. M. Paterson, P. W.F. Hadoke, N. Wrobel, C. O.C. Bellamy, D. G. Brownstein, J. R. Seckl, and J. J. Mullins
A Switch in the Mechanism of Hypertension in the Syndrome of Apparent Mineralocorticoid Excess
J. Am. Soc. Nephrol., January 1, 2008; 19(1): 47 - 58.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Oberleithner, C. Riethmuller, H. Schillers, G. A. MacGregor, H. E. de Wardener, and M. Hausberg
Plasma sodium stiffens vascular endothelium and reduces nitric oxide release
PNAS, October 9, 2007; 104(41): 16281 - 16286.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. J. Pinho, M. P. Serrao, and P. Soares-da-Silva
High-salt intake and the renal expression of amino acid transporters in spontaneously hypertensive rats
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1452 - F1463.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Yang, K. Venardos, E. Jones, B. J. Morris, J. Chin-Dusting, and D. M. Kaye
Identification of a Novel Polymorphism in the 3'UTR of the L-Arginine Transporter Gene SLC7A1: Contribution to Hypertension and Endothelial Dysfunction
Circulation, March 13, 2007; 115(10): 1269 - 1274.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. P. Provoost
Does Angiotensin Receptor Recycling Regulate Blood Pressure?
Hypertension, September 1, 2006; 48(3): 370 - 371.
[Full Text] [PDF]


Home page
Circ. Res.Home page
R. Inoue, L. J. Jensen, J. Shi, H. Morita, M. Nishida, A. Honda, and Y. Ito
Transient Receptor Potential Channels in Cardiovascular Function and Disease
Circ. Res., July 21, 2006; 99(2): 119 - 131.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.